MAPT and Alzheimer disease: Recent reports have shown that the second-generation tau PET tracer MK6240 binds selectively and specifically to one site on the NFT-rich AD brain tissue and neither binds to off-target sites nor has an affinity for amyloid plaques [19,20,21].